Birmingham, West Midlands -- (SBWIRE) -- 10/02/2013 -- Value Penny Stocks issues special report on: Merrimack Pharma (NASDAQ:MACK), Spirit Realty Capital Inc (NYSE:SRC), Anacor Pharma (NASDAQ:ANAC), Rockwell Medical, Inc. (NASDAQ:RMTI)
Merrimack Pharma (NASDAQ:MACK) finishes enrollment of neoadjuvant Phase 2 study of MM-121 in HER2-negative breast cancer. The company declared on Tuesday that the last patient has been registered in the second cohort of a two-cohort randomized Phase 2 clinical trial of MM-121 in combination with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer.
Spirit Realty Capital Inc (NYSE:SRC) is a self-administered and self-supervised real estate investment trust (REIT). The firm’s operations are performed through Spirit Realty, L.P. (the Operating Partnership).Spirit Realty Capital Inc (NYSE:SRC) traded up 0.49% on a market cap of 3.44 billion, with opening price of $9.22. Spirit Realty Capital, in spite of a hefty pre-market decline, shares have upturned and ended the session above the trend line while its past five days showed negative change of -49%.
Anacor Pharma (NASDAQ:ANAC) declares FDA approval of tavaborole NDA for filing The company declared that its New Drug Application (NDA) for tavaborole, its drug applicant for the topical treatment of onychomycosis, has been approved by the US Food and Drug Administration (FDA) showing that the application is adequately finish to allow a substantive review.
Rockwell Medical, Inc. (NASDAQ:RMTI), previously Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States. Rockwell Medical, Inc. (NASDAQ:RMTI) saw its price fall on below-normal volume, as 102,318.00 shares changed hands when compared with its average daily volume of 3.44 million shares. The stock was down -2.02% to $11.62. It has fallen over the last 12 months, dropping-12.04% and marked new low $8.88.
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)